Replies to post #122647 on Biotech Values

[DewDiligence]

NVS’ QAB149 (Onbrez) approved in Japan at 150mcg dose:

http://www.novartis.com/newsroom/media-releases/en/2011/1527927.shtml

The importance of the QAB149 150mcg dose for the QVA149 combination product is discussed in the prologue of #msg-64761738.

QAB149 monotherapy is now approved in every major country (more than 60 countries in all) except the US, where the PDUFA date is today.

[DewDiligence]

Correction to prologue of #msg-64761738: where it says the PDUFA date for QAB149 monotherapy is 7/31/11, it should say 7/1/11 (today).